This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mueller-Ortiz, S. L.
Right arrow Articles by Wetsel, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mueller-Ortiz, S. L.
Right arrow Articles by Wetsel, R. A.

 Previous Article  |  Next Article 

Infection and Immunity, May 2004, p. 2899-2906, Vol. 72, No. 5
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.5.2899-2906.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

The Alternative Activation Pathway and Complement Component C3 Are Critical for a Protective Immune Response against Pseudomonas aeruginosa in a Murine Model of Pneumonia

Stacey L. Mueller-Ortiz,1 Scott M. Drouin,1 and Rick A. Wetsel1,2*

Research Center for Immunology and Autoimmune Diseases, Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas—Houston,1 Department of Biochemistry and Molecular Biology, University of Texas—Houston Medical School, Houston, Texas 770302

Received 24 July 2003/ Returned for modification 5 September 2003/ Accepted 21 January 2004

Pseudomonas aeruginosa is a leading cause of hospital-acquired pneumonia, and approximately 80% of patients with cystic fibrosis are infected with this bacterium. To investigate the overall role of complement and the complement activation pathways in the host defense against P. aeruginosa pulmonary infection, we challenged C3-, C4-, and factor B-deficient mice with P. aeruginosa via intranasal inoculation. In these studies, C3–/– mice had a higher mortality rate than C3+/+ mice. Factor B–/– mice, but not C4–/– mice, infected with P. aeruginosa had a mortality rate similar to that of C3–/– mice, indicating that in this model the alternative pathway of complement activation is required for the host defense against Pseudomonas infection. C3–/– mice had 6- to 7-fold more bacteria in the lungs and 48-fold more bacteria in the blood than did C3+/+ mice at 24 h postinfection. In vitro, phagocytic cells from C3+/+ or C3–/– mice exhibited a decreased ability to bind and/or ingest P. aeruginosa in the presence of C3-deficient serum compared to phagocytic cells in the presence of serum with sufficient C3. C3–/– mice displayed a significant increase in neutrophils in the lungs and had higher levels of interleukin-1ß (IL-1ß), IL-6, IL-10, KC, and MIP-2 in the lungs at 24 h postinfection than did C3+/+ mice. Collectively, these results indicate that complement activation by the alternative pathway is critical for the survival of mice infected with P. aeruginosa and that the protection provided by complement is at least in part due to C3-mediated opsonization and phagocytosis of P. aeruginosa.

* Corresponding author. Mailing address: Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas—Houston, 2121 W. Holcombe Blvd., Suite 907, Houston, TX 77030. Phone: (713) 500-2412. Fax: (713) 500-2420. E-mail: Rick.A.Wetsel{at}uth.tmc.edu.

Editor: J. N. Weiser

Infection and Immunity, May 2004, p. 2899-2906, Vol. 72, No. 5
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.5.2899-2906.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Weimer, E. T., Lu, H., Kock, N. D., Wozniak, D. J., Mizel, S. B. (2009). A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa. Infect. Immun. 77: 2356-2366 [Abstract] [Full Text]  
  • Mizgerd, J. P. (2008). Acute Lower Respiratory Tract Infection. NEJM 358: 716-727 [Full Text]  
  • Lalli, P. N., Strainic, M. G., Lin, F., Medof, M. E., Heeger, P. S. (2007). Decay Accelerating Factor Can Control T Cell Differentiation into IFN-{gamma}-Producing Effector Cells via Regulating Local C5a-Induced IL-12 Production. J. Immunol. 179: 5793-5802 [Abstract] [Full Text]  
  • Al-Rayes, H., Al-Swailem, R., Arfin, M., Sobki, S., Rizvi, S., Tariq, M. (2007). Lupus Around the World: Systemic lupus erythematosus and infections: a retrospective study in Saudis. Lupus 16: 755-763 [Abstract]  
  • Kunert, A., Losse, J., Gruszin, C., Huhn, M., Kaendler, K., Mikkat, S., Volke, D., Hoffmann, R., Jokiranta, T. S., Seeberger, H., Moellmann, U., Hellwage, J., Zipfel, P. F. (2007). Immune Evasion of the Human Pathogen Pseudomonas aeruginosa: Elongation Factor Tuf Is a Factor H and Plasminogen Binding Protein. J. Immunol. 179: 2979-2988 [Abstract] [Full Text]  
  • Woodman, M. E., Cooley, A. E., Miller, J. C., Lazarus, J. J., Tucker, K., Bykowski, T., Botto, M., Hellwage, J., Wooten, R. M., Stevenson, B. (2007). Borrelia burgdorferi Binding of Host Complement Regulator Factor H Is Not Required for Efficient Mammalian Infection. Infect. Immun. 75: 3131-3139 [Abstract] [Full Text]  
  • Thurman, J. M., Holers, V. M. (2006). The Central Role of the Alternative Complement Pathway in Human Disease. J. Immunol. 176: 1305-1310 [Abstract] [Full Text]  
  • Takahashi, K., Shi, L., Gowda, L. D., Ezekowitz, R. A. B. (2005). Relative Roles of Complement Factor 3 and Mannose-Binding Lectin in Host Defense against Infection. Infect. Immun. 73: 8188-8193 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»